Ryvu Therapeutics S.A. (WSE:RVU)
Poland · Delayed Price · Currency is PLN 15.00
-0.12 (-0.79%)
Jul 24, 2026, 5:00 PM CET
Ryvu Therapeutics Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Ryvu Therapeutics stock has a consensus rating of "Buy" and an average price target of zł 33.62. The average 1-year stock price forecast is 124.13% higher than the current stock price, while the lowest is zł 17.00 (+13.33%) and the highest is zł 49.10 (+227.33%).
Price Target: zł 33.62 (+124.13%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Ryvu Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 2 | 2 | 2 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 5 | 5 |
Financial Forecast
Revenue This Year
86.73M
from 87.70M
Decreased by -1.11%
Revenue Next Year
82.97M
from 86.73M
Decreased by -4.34%
EPS This Year
-2.06
from -4.40
EPS Next Year
-2.25
from -2.06
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is PLN.